UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054397
Receipt number R000062137
Scientific Title Evaluation of the usefulness of a lower limb trestle utilizing a new type of wool mat for skin graft patients.
Date of disclosure of the study information 2024/08/31
Last modified on 2024/11/13 11:39:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the usefulness of a lower limb trestle utilizing a new type of wool mat for skin graft patients.

Acronym

Evaluation of the usefulness of a lower limb trestle utilizing a new type of wool mat for skin graft patients.

Scientific Title

Evaluation of the usefulness of a lower limb trestle utilizing a new type of wool mat for skin graft patients.

Scientific Title:Acronym

Evaluation of the usefulness of a lower limb trestle utilizing a new type of wool mat for skin graft patients.

Region

Japan


Condition

Condition

Patients with skin implants

Classification by specialty

Plastic surgery Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

In this study, we will compare and verify the comfort of a new wool mat for lower limb trestles for patients with skin implants, and investigate its usefulness in actual clinical practice.

Basic objectives2

Others

Basic objectives -Others

Comfort verification of new wool mats

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Questionnaires and Interviews with Patients
Questionnaire for nurses

Key secondary outcomes

None


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Maneuver Other

Interventions/Control_1

If Monday is the surgery day, Group A will use the normal lower limb trestle from Tuesday after extubation to the third postoperative day, and from Friday afternoon of the fourth day, a lower limb trestle with a new type of wool mat wrapped around it will be used, and the survey and interview will be completed on Monday afternoon.

Interventions/Control_2

If Monday is the day of surgery, Group B will use a lower limb trestle with a new type of wool mat wrapped around it from Tuesday after extubation to the third postoperative day, and from Friday afternoon of the fourth day, a regular lower limb trestle will be used, which will be completed on Monday afternoon and questionnaires and interviews will be conducted.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

Patients:
Patients who have undergone skin grafting and whose attending physicians determine that they are eligible for the study will be included. The patients will be assigned a number when they agree to cooperate in the study. This will be a randomized controlled trial, with odd numbers assigned to group A and even numbers assigned to group B. The study will be conducted on three days during the six-day postoperative period, one day using the new wool mat wrapped lower limb trestle and three days using the conventional lower limb trestle, so that eligible patients will experience both types of lower limb trestles.
Nurses:
Nurses who were engaged in care (patient observation and nursing activities including daily ward duties such as blood pressure monitoring and wiping) during the study period.

Key exclusion criteria

Patients:
Exclusion criteria will be patients deemed inappropriate by the attending physician and those who have developed skin problems, are in severe mental or physical distress, or whose consent could not be obtained.
Nurses:
Those for whom consent could not be obtained.

Target sample size

140


Research contact person

Name of lead principal investigator

1st name YOSHIE
Middle name
Last name IMAI

Organization

Tokushima University

Division name

Cancer Nursing

Zip code

770-8509

Address

3-18-15 Kuramoto-cho, Tokushima,

TEL

088-633-9038

Email

imai@tokushima-u.ac.jp


Public contact

Name of contact person

1st name yoshie
Middle name
Last name IMAI

Organization

Tokushima University

Division name

Cancer nursing

Zip code

770-8509

Address

3-18-15 Kuramoto-cho, Tokushima,

TEL

088-633-9038

Homepage URL


Email

imai@tokushima-u.ac.jp


Sponsor or person

Institute

Tokushima University

Institute

Department

Personal name

YOSHIE IMAI


Funding Source

Organization

Tokushima University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Ethics Committee of Tokushima University Hospital

Address

2-50-1, Kuramoto-cho, Tokushima

Tel

088-631-3111

Email

first-ec@tokushima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

徳島大学病院(徳島県)


Other administrative information

Date of disclosure of the study information

2024 Year 08 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2024 Year 08 Month 31 Day

Date of IRB

2024 Year 09 Month 30 Day

Anticipated trial start date

2024 Year 08 Month 31 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 05 Month 14 Day

Last modified on

2024 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062137